Literature DB >> 31647067

A cyanine-derivative photosensitizer with enhanced photostability for mitochondria-targeted photodynamic therapy.

Xuan Zhao1, Yanjun Yang2, Yan Yu3, Siming Guo1, Wenxing Wang3, Sumin Zhu1.   

Abstract

A cyanine-derivative photosensitizer, CYBF2, was synthesized for photodynamic therapy of cancer. The photosensitizer can be activated by red-light with enhanced photostability compared to traditional cyanine photosensitizers. CYBF2 was able to generate singlet oxygen inside the cell mitochondria, which efficiently resulted in apoptosis of cancer cells.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31647067     DOI： 10.1039/c9cc06157f

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  4 in total

Review 1.  Heptamethine Cyanine-Based Application for Cancer Theranostics.

Authors:  Lei Zhang; Hang Jia; Xuqian Liu; Yaxin Zou; Jiayi Sun; Mengyu Liu; Shuangshuang Jia; Nan Liu; Yanzhang Li; Qun Wang
Journal:  Front Pharmacol       Date:  2022-02-11       Impact factor: 5.810

Review 2.  Recent advances in small molecule dye-based nanotheranostics for NIR-II photoacoustic imaging-guided cancer therapy.

Authors:  Wen Zhou; Likun Yin; Xuheng Zhang; Tingting Liang; Zixin Guo; Yaxin Liu; Chen Xie; Quli Fan
Journal:  Front Bioeng Biotechnol       Date:  2022-09-29

Review 3.  Recent Advances in Cyanine-Based Phototherapy Agents.

Authors:  Kubra Bilici; Sultan Cetin; Eda Aydındogan; Havva Yagci Acar; Safacan Kolemen
Journal:  Front Chem       Date:  2021-06-24       Impact factor: 5.221

Review 4.  Potential of Cyanine Derived Dyes in Photodynamic Therapy.

Authors:  Natalia Lange; Wojciech Szlasa; Jolanta Saczko; Agnieszka Chwiłkowska
Journal:  Pharmaceutics       Date:  2021-05-31       Impact factor: 6.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.